Literature DB >> 3894034

Immunohistochemistry of a component protein of the breast cystic disease fluid with mol. wt 15,000.

V Le Doussal, P F Zangerle, J Collette, F Spyratos, K Hacene, M Briere, P Franchimont, J Gest.   

Abstract

A specific protein from the liquid of a mammary cyst with a molecular weight of 15,000 (GCDFP 15) was studied in normal and pathological mammary tissue using an immunohistochemical method (peroxidase-anti-peroxidase complex). An immunoreactivity of the GCDFP type was found in normal idrosadenoid glands having an apocrine secretion. Histologically normal mammary tissue was not immunoreactive. In benign breast tissue the GCDFP was found particularly in epithelium undergoing apocrine metaplasia (55/55) and in atypical lobular epithelial hyperplasia (8/10). Of the adenocarcinomas of the breast 136/161 (84%) were immunoreactive, especially lobular carcinoma (13/13). The proportion of tumors with a high percentage of immunoreactive cells (76-100%) was greater for Bloom's grade I (1/29: 34%) than for grade III (10/66: 15%). A significant correlation was found between the percentage of immunoreactive cells and the cytosolic concentration of progesterone receptors. The morphological intracellular identification of GCDFP (due to its greater sensitivity) and its correlation with progesterone receptors allowed a more precise evaluation of the functional state and the hormonal dependency of the breast cells by underlining the heterogeneity of the tumoral cell population.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3894034     DOI: 10.1016/0277-5379(85)90269-x

Source DB:  PubMed          Journal:  Eur J Cancer Clin Oncol        ISSN: 0277-5379


  3 in total

1.  PIP/GCDFP-15 gene expression and apocrine differentiation in carcinomas of the breast.

Authors:  A Pagani; A Sapino; V Eusebi; P Bergnolo; G Bussolati
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

2.  Is apocrine differentiation in breast carcinoma of prognostic significance?

Authors:  N J Bundred; R A Walker; D Everington; G K White; H J Stewart; W R Miller
Journal:  Br J Cancer       Date:  1990-07       Impact factor: 7.640

3.  Secreted indicators of androgen receptor activity in breast cancer pre-clinical models.

Authors:  Toru Hanamura; Jessica L Christenson; Kathleen I O'Neill; Emmanuel Rosas; Nicole S Spoelstra; Michelle M Williams; Jennifer K Richer
Journal:  Breast Cancer Res       Date:  2021-11-04       Impact factor: 6.466

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.